Updates are available Correction dated 2021-05-16
Click to view Correction: https://doi.org/10.1245/s10434-021-10138-3
-
Authors
Shah, Chirag
Bremer, Troy
Cox, Charles
Whitworth, Pat
Patel, Rakesh
Patel, Anushka
Brown, Eric
Gold, Linsey
Rock, David
Riley, Lee
Kesslering, Christy
Brown, Sheree
Gabordi, Robert
Pellicane, James
Rabinovich, Rachel
Khan, Sadia
Templeton, Sandra
Majithia, Lonika
Willey, Shawna C.
Wärnberg, Fredrik
Gerber, Naamit K.
Shivers, Steve
Vicini, Frank A.
-
Funding
Funding for this research was provided by:
PreludeDX
- License Information
-
More Information
Article History
Received: 4 December 2020
Accepted: 8 March 2021
First Online: 5 April 2021
Change Date: 16 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-021-10138-3
Disclosure
: Chirag Shah, MD, is a consultant for Impedimed and PreludeDX, and has received grants from Varian Medical Systems, VisionRT, and PreludeDx. Troy Bremer is the Chief Scientific Officer of PreludeDx; he co-invented the technology and is named as an inventor. James Pellicane is a member of the speaker’s bureau, and owns stock options. Steve Shivers is an employee of PreludeDx and owns stock in PreludeDx. Christy Kesslering has received speaker’s bureau fees. Rakesh Patel and Pat Whitworth are Directors of TME, which has received grants from multiple biotech companies and PreludeDx. Frank Vicini is a Research Advisor for PreludeDx and a consultant with ImpediMed. Co-authors participating in this study received a stipend from PreludeDx to cover the ethics approval expenses, and a nominal fee to cover patient enrollment and completion of survey data for the study.
